Hiku Brands Company Ltd. (“Hiku”)(CSE:HIKU,OTCUS:DJACF), Canada’s first vertically-integrated cannabis brand house, is pleased to announce it has entered into a letter of intent to establish a co-marketing, retail and select distribution relationship with dosist (previously known as hmbldt), a leading wellness brand recognized as a disruptor in the health industry and named by Fast Company as one of the world’s 10 most innovative companies in the health sector in 2018.

Once dosist cannabis products become legally permitted to be sold for adult-use in Canada, consumers will be able to purchase dosist’s highly innovative targeted formulas at Hiku-owned licensed cannabis stores. In select areas, where permitted, Hiku-owned licensed cannabis stores will feature an immersive dosist experience where Hiku will be the exclusive retailer of dosist products.


“Hiku is focused on bringing Canadians truly exceptional products and experiences, and dosist fits perfectly into our growing family of brands and partners. Hiku and dosist are committed to helping Canadians understand the cannabis landscape and consume in a responsible manner,” says Alan Gertner, CEO of Hiku. “We’re excited to bring dosist’s amazing products to Canadians soon, and in the meantime, work with them to continue to educate, inform and normalize cannabis for consumers.”

dosist is dedicated to providing consistent, controlled and effective cannabis-based solutions through targeted formulations of the active ingredients found in cannabis. The company delivers precise dosage through its recyclable, proprietary, medical grade vaporizer, the dose pen™. dosist’s products are designed for clarity and control from their beautifully designed packaging to the slight vibration which alerts the user after they’ve received a precise 2.25mg dose. dosist’s targeted formulas and propriety dose pen were named one of TIME magazine’s best inventions of 2016.

“We’re thrilled to be working with Hiku. They’ve demonstrated a commitment to cannabis-related education, working to remove the stigma surrounding the plant,” said Josh Campbell, President of dosist. “We chose Hiku because of their vision for the future and their commitment to the best in class customer experience.”

About Hiku:
Hiku is focused on building a portfolio of iconic, engaging cannabis brands, unsurpassed retail experiences and handcrafted cannabis production. With a national retail footprint led by Tokyo Smoke, craft cannabis production through DOJA‘s ACMPR licensed grow, and Van der Pop‘s female-focused educational platforms, Hiku houses an industry-leading portfolio that sets the bar for cannabis brands in Canada.

Hiku’s wholly-owned subsidiary, DOJA Cannabis Ltd., is a federally licensed producer pursuant to the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”), owning two production facilities in the heart of British Columbia’s Okanagan Valley. The company operates a network of retail stores selling coffee, clothing and curated accessories, across British Columbia, Alberta and Ontario.

About dosist™: 
Named one of Time Magazine’s Best Inventions of 2016, dosist™ is a cannabis-based wellness company. Through six targeted formulas, dosist aims to deliver safe, targeted and effective solutions for some of our most common ailments. The company takes an ethical approach to production, which includes fully recyclable, medical-grade plastic and a rigorous testing process to ensure all products are safe and pesticide-free. www.dosist.ca @dosist.ca

Regarding Forward-Looking Information

This news release contains statements that constitute “forward-looking statements”. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Hiku’s actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects,” “plans”, “anticipates”, “believes”, “intends”, “estimates”, “projects”, “potential” and similar expressions, or that events or conditions “will”, “would”, “may”, “could” or “should” occur.

Forward-looking statements in this news release include statements regarding Hiku’s expectations regarding the availability of dosist’s targeted formulas and products in Hiku owned stores.  By their nature, forward-looking statements are based on the opinions and estimates of management at the date the information is made, and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. Hiku is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

The Canadian Securities Exchange has not approved nor disapproved the contents of this news release.

For Hiku press inquiries or to book an interview, please contact:
Abigail Van Den Broek abby@abigailv.ca; 416-799-8510

For dosist™ press inquiries or to book an interview, please contact:
Lexi Pathak (Toronto) lexi@dosist.com; Faulhaber Communications, 416-504-0768 x 227
Malania Dela Cruz (Vancouver) malania@dosist.com; Faulhaber Communications, 778-379-6222

Click here to connect with Hiku Brands Company Ltd. and receive an Investor’s Presentation.

Source: globenewswire.com

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less